[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-458942-105":59,"doc-detail-458942-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prevalence-and-determinants-of-polypharmacy-a-cross-sectional-study-among-elderly-patients-with-cardiovascular-diseases-in-outpatient-clinics","Prevalence and Determinants of Polypharmacy - A Cross-Sectional Study Among Elderly Patients With Cardiovascular Diseases in Outpatient Clinics","","Polypharmacy, the concurrent use of five or more medications, represents a major public health challenge for older adults with cardiovascular disease due to its links with adverse drug–drug interactions, medication errors, and increased hospitalization. Evidence from low- and middle-income settings, including Iran, remains limited. This cross-sectional study enrolled 426 elderly cardiovascular patients in Kermanshah using structured questionnaires and analyzed data with chi-square tests and multivariate logistic regression to identify determinants. Results showed 60.1% taking 5–9 medications daily and highlighted predictors including lower education and income, longer treatment duration, hospitalization history, multimorbidity, inadequate pharmacist counseling, and poor medication knowledge.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-and-determinants-of-polypharmacy-a-cross-sectional-study-among-elderly-patients-with-cardiovascular-diseases-in-outpatient-clinics/458942/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-and-determinants-of-polypharmacy-a-cross-sectional-study-among-elderly-patients-with-cardiovascular-diseases-in-outpatient-clinics/458942.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study?","Question",{"text":112,"@type":113},"To determine the prevalence of polypharmacy and identify key determinants among elderly patients with cardiovascular diseases attending outpatient clinics in Kermanshah, Iran.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was polypharmacy measured and what prevalence was found?",{"text":117,"@type":113},"Polypharmacy was defined as the concurrent use of five or more medications. The study found that 60.1% of participants were taking five to nine medications daily.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were identified as independent predictors?",{"text":121,"@type":113},"Multivariate analysis identified the number of chronic conditions, hospitalization history, and poor medication knowledge as independent predictors of polypharmacy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},458942,1790792291,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Wiley  \nScientifica  \nVolume 2025, Article ID 6641747, 11 pages [https://doi.org/10.1155/sci5/6641747](https://doi.org/10.1155/sci5/6641747)  \nResearch Article  \nPrevalence and Determinants of Polypharmacy: ACross-Sectional Study Among Elderly Patients With Cardiovascular Diseases in Outpatient Clinics  \nNegin Faramarzi Nasab,1 Shahab Rezaeian ,2 Saeed Ezadi,3 and Alireza Khatony 2,3  \n1 Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran  \n2 Infectious Diseases Research Centre, Health Policy and Promotion Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran  \n3 Social Development and Health Promotion Research Center, Health Policy and Promotion Institute,  \nKermanshah University of Medical Sciences, Kermanshah, Iran  \nCorrespondence should be addressed to Alireza Khatony; [akhatony@gmail.com](akhatony@gmail.com)  \nReceived 17 August 2025; Revised 22 November 2025; Accepted 2 December 2025  \nAcademic Editor: Abdel Halim Salem  \nCopyright © 2025 Negin FaramarziNasabet al. Scientifca published by John Wiley & Sons Ltd. Tis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nPolypharmacy, commonly defned as the concurrent use offve or more medications, is a pressing public health concern among older adults with cardiovascular disease, given its strong association with adverse drug–drug interactions, medication errors, and increased hospitalization rates. Despite its clinical signifcance, evidence from low-and middle-income countries, including Iran, remains limited. Tis study sought to determine the prevalence of polypharmacy and identify its key determinants among elderly cardiovascular patients in Kermanshah, Iran. In this cross-sectional survey of 426 participants, eligible participants were recruited using convenience sampling, and demographic, clinical, and medication-related data were collected using structured questionnaires. Statistical analyses, including chi-square tests and multivariate logistic regression, were employed to examine associations. Te fndings revealed that 60.1% of participants were taking fve to nine medications daily. Polypharmacy was signifcantly associated with lower educational attainment and income, prolonged treatment duration, hospitalization history, multimorbidity, insufcient pharmacist counseling, and limited knowledge of medications and their potential adverse efects. Multivariate analysis identifed the number of chronic conditions (AOR: 5.05, p \u003C 0.001), hospitalization history (AOR: 5.15, p \u003C 0.001), and poor medication knowledge (AOR: 6.48, p 􀂈 0.017), as independent predictors. Tese results highlight the urgent need for targeted, evidence-based interventions, particularly pharmacist-led counseling and patient education programs, to mitigate the burden and adverse clinical outcomes of polypharmacy, especially in resource-constrained healthcare settings.  \nKeywords: cardiovascular diseases; elderly; polypharmacy; prevalence  \n1. Introduction  \nTe global population is aging rapidly, with projections indicating that 1.5 billion people worldwide will be aged 65 or older by 2050 [1] . Tis demographic shift is mirrored in Iran, where individuals aged 60 and above constituted over 10% of the total population in 2022 [2]. Among this growing elderly population, cardiovascular diseases (CVDs) area leading cause of morbidity and mortality [3] . CVDs are particularly relevant to polypharmacy research because their  \nmanagement typically requires long-term and multidrug therapeutic regimens, which place elderly patients at substantially higher risk of inappropriate medication use compared with other chronic illnesses [4, 5] . Tis clinical complexity makes elderly CVD patients a priority population for investigating polypharmacy.  \nPolypharmacy, commonly defned as the concurrent use offve or more medication","cbCaic7LkxdsZXk8","https://ap.wps.com/l/cbCaic7LkxdsZXk8","pdf",573766,11,"English","# Introduction\n# Study Methods\n## Sampling and Participants\n## Data Collection\n## Statistical Analysis\n# Results\n## Prevalence of Polypharmacy\n## Univariate Associations\n## Multivariate Logistic Regression\n# Discussion\n## Key Determinants\n## Clinical and Public Health Implications\n# Conclusion","[{\"question\":\"What is the main objective of the study?\",\"answer\":\"To determine the prevalence of polypharmacy and identify key determinants among elderly patients with cardiovascular diseases attending outpatient clinics in Kermanshah, Iran.\"},{\"question\":\"How was polypharmacy measured and what prevalence was found?\",\"answer\":\"Polypharmacy was defined as the concurrent use of five or more medications. The study found that 60.1% of participants were taking five to nine medications daily.\"},{\"question\":\"Which factors were identified as independent predictors?\",\"answer\":\"Multivariate analysis identified the number of chronic conditions, hospitalization history, and poor medication knowledge as independent predictors of polypharmacy.\"}]","Prevalence and Determinants of Polypharmacy - A Cross-Sectional Study Among Elderly Patients With Cardiovascular Diseases in Outpatient Clinics | PDF",1790754807,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c1bbd7ab74da2eb8d8f352adea3439f5.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/69488121cf0172ee5670e120ac90f165.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/3e7d4c3822b95b96cba84d853453d68d.webp",981,1307,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ec4dc74b51648138a86185967981464b.webp",980,1306]